Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

More than 500 to graduate this summer
2015-11-30

A total of 544 graduates will walk across the stage to collect their hard-earned qualifications at this year’s Summer Graduation on the Bloemfontein Campus.

A total of 106 Master’s Degrees and 39 Doctorates will be conferred by all seven faculties of the University of the Free State (UFS). About 231 pre-graduates are expected from the Faculty of Health Sciences. The School of Open Learning will proudly award 122 Diplomas and 46 Certificates.

Prof Busisiwe Rosemary Bhengu, Chairperson of the South African Nursing Council, will be the guest speaker for the day.

About the guest speaker

Prof Bhengu holds a PhD in Nursing, and is an Honorary Associate Professor at the University of KwaZulu-Natal (UKZN). From 2008, Bhengu has headed the UKZN School of Nursing.  She has supervised and co-supervised several PhD and Master’s students.

In addition to teaching Critical Care Nursing at both local and international levels, Bhengu was responsible for the development of the Nurse Specialist syllabus at the university. Her contributions to the field reach as far as the United Arab Emirates, Kenya, Tanzania, Eritrea, Rwanda, and Seychelles, where she pioneered course development and implementation for critical care nursing in the curriculum for Nurse Anaesthetics in Rwanda.

Other leadership positions held by Prof Bhengu include directing the World Health Organisation Collaborating Centre in the UKZN School of Nursing between 2008 and 2011; representing the Afro-Region at the Executive Committee of the Global Network; chairing the Professional Conduct Committee; and the Laws, Practice and Standards Committee. She has published many papers internationally.

A musical prelude

The Sonnedou residence Kleinser group will deliver a few musical items for the graduates, friends, and family.

Details of event

Date:
Thursday 10 December 2015
Time:  08:00am and 14:30pm
Place: Callie Human Centre, Bloemfontein Campus

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept